Analysis of methadone and its metabolites in meconium by enzyme immunoassay (EMIT®) and GC-MS

Journal of Analytical Toxicology

Volumn 25, Issue 1, 2001, Pages 40-44

  ElSohly, M A ^a   Feng, S ^a   Murphy, T P ^a  

^a ElSohly Laboratories Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 5 METHYL 3,3 DIPHENYLPYRROLIDINE; 2 ETHYLIDENE 1,5 DIMETHYL 3,3 DIPHENYLPYRROLIDINE; DRUG METABOLITE; METHADONE; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DETERMINATION; DRUG ISOLATION; DRUG SCREENING; ENZYME IMMUNOASSAY; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; MECONIUM; PRENATAL EXPOSURE; QUANTITATIVE ASSAY;

EID: 0035140442     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/25.1.40     Document Type: Article

References (8)

1. Issues of risk assessment: Lessons from the use and abuse of drugs during pregnancy
2. Prenatal administration of methadone using the osmotic minipump: Effects on maternal and offspring toxicity, growth, and behavior in the rat
3. Prenatal methadone exposure produces physical dependence and altered behavioral development in the rat
4. Testing for exposure to illicit drugs and other agents in the neonate: A review of laboratory methods and the role of meconium analysis
5. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy
6. Analysis of methadone and its primary metabolite in meconium
7. Spectrum of gestational exposure to illicit drugs and other xenobiotic agents in newborn infants by meconium analysis
8. Immunoassay and GC-MS procedures for analysis of drugs of abuse in meconium